Stock detail
Alumis (ALMS) stock price, chart, and key data
View Alumis stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Alumis
ALMS · XNAS
$7.06
-1.40%
-$0.10
Pre-market $7.11 (+0.71%)
Key metrics
52-week range
$1.50 - $3.00
Close price
$7.16
Market cap
$926.8M
P/E ratio
-6.48
Beta
1.23
About the company
Alumis Inc
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$29.50
7
Buy
/ 8
Recent calls
10/05/2026
H.C. Wainwright
Mitchell Kapoor
Buy · Price target $15.00
09/09/2026
Wells Fargo
Derek Archila
Buy · Price target $25.00
09/02/2026
Raymond James
Christopher Raymond
Buy
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app